Predictive factors of head and neck squamous cell carcinoma patient tolerance to high-dose cisplatin in concurrent chemoradiotherapy

Although high-dose cisplatin is the standard regimen of concurrent chemoradiotherapy (CCRT) for locally advanced head and neck squamous cell carcinoma (HNSCC), varying levels of patient tolerance towards cisplatin have been reported, and the predictive factors of cisplatin tolerance remain to be elu...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Mol Clin Oncol
Päätekijät: NAKANO, KENJI, SATO, YASUYOSHI, TOSHIYASU, TAKASHI, SATO, YUKIKO, INAGAKI, LINA, TOMOMATSU, JUNICHI, SASAKI, TORU, SHIMBASHI, WATARU, FUKUSHIMA, HIROFUMI, YONEKAWA, HIROYUKI, MITANI, HIROKI, KAWABATA, KAZUYOSHI, TAKAHASHI, SHUNJI
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: D.A. Spandidos 2016
Aiheet:
Articles
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4734196/
https://ncbi.nlm.nih.gov/pubmed/26893880
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2015.687
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia